Invention Grant
- Patent Title: Delivery and formulation of engineered nucleic acids
- Patent Title (中): 交付和配制工程核酸
-
Application No.: US14337513Application Date: 2014-07-22
-
Publication No.: US09533047B2Publication Date: 2017-01-03
- Inventor: Antonin de Fougerolles , Sayda M. Elbashir
- Applicant: ModernaTX, Inc.
- Applicant Address: US MA Cambridge
- Assignee: MODERNATX, INC.
- Current Assignee: MODERNATX, INC.
- Current Assignee Address: US MA Cambridge
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Main IPC: A61K47/18
- IPC: A61K47/18 ; A61K38/19 ; A61K38/48 ; A61K47/22 ; A61K47/28 ; A61K31/7088 ; C12N15/87 ; A61K31/7115 ; C07K14/535 ; C12N9/64 ; A61K48/00
Abstract:
Provided are formulations, compositions and methods for delivering biological moieties such as modified nucleic acids into cells to modulate protein expression. Such compositions and methods include the delivery of biological moieties, and are useful for production of proteins.
Public/Granted literature
- US20150017211A1 DELIVERY AND FORMULATION OF ENGINEERED NUCLEIC ACIDS Public/Granted day:2015-01-15
Information query
IPC分类:
